PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore.\', \'Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore.\', \'Division of Medical Oncology, National Cancer Centre Singapore, Singapore.\', \'Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.\', \'Division of Supportive & Palliative Care, National Cancer Centre Singapore, Singapore.\', \'Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.\', \'Department of Pharmacy, National Cancer Centre Singapore, Singapore.\', \'Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.\', \'Executive Offices, National Cancer Centre Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1200/OP.20.00535
?:doi
?:hasPublicationType
?:journal
  • JCO oncology practice
is ?:pmid of
?:pmid
?:pmid
  • 33439694
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Early Outcomes of a National Cancer Center\'s Strategy Against COVID-19 Executed Through a Disease Outbreak Response Taskforce.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all